Good to hear and great post as always stervc. I think the following key catalysts will help AMS succeed in completing the inspections and obtaining the required approvals from Health Canada once they obtain the financing approvals:
# 1 Changing legislative and political environment to be more open to MJ in Canada
# 2 Increasing demand for MMJ in Canada
# 3 Government's objective to ensure there is enough MMJ supply for Canadian patients' demand
# 4 Big Canadian Pharma wanting to distribute MMJ
I think all of these catalyst are lining up the stars for BLDV and AMS and putting them both in the right spot at the right time (i.e. the perfect storm). I will post more on these catalysts in response to your great post.
BLDV's strategy is smart to help AMS get the financing to get to the finish line and bring AMS into BLDV as a wholly owned subsidiary. A win-win situation for both.
Go BLDV!
Buy cautiously and sell reluctantly. All of my posts are In My Opinion only based on the DD I have completed. Please do your own DD and make your own decisions.